OpenBilldrug price receipt

NADAC week of 2026-10-14

SOLIFENACIN 10 MG TABLET

For 30 tablets

Pharmacies pay

$4.85 filed

30 × $0.16167 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$24.65 filed

30 × $0.82163 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.1× estimated

Medicare paid 5.1× what pharmacies pay.

Part D averages every strength and form sold under “Solifenacin Succinate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$10.58 estimated

$4.85 + $0.73 (15%) + $5.00 fee per fill = $10.58

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

SOLIFENACIN 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as solifenacin succinate.

FDA gives its dosage form as “tablet, film coated”, “tablet, coated”, “tablet, film coated, extended release” and “tablet” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Unichem Pharmaceuticals (USA), Inc. and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Cholinergic Muscarinic Antagonist.

The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4.85 for 30 tablets (30 × $0.16167 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Actavis Pharma, Inc.2$0.16167 per EA filed
Alembic Pharmaceuticals Inc.2$0.16167 per EA filed
Ascend Laboratories, LLC2$0.16167 per EA filed
Aurobindo Pharma Limited2$0.16167 per EA filed
Camber Pharmaceuticals, Inc.2$0.16167 per EA filed
Glenmark Pharmaceuticals Inc., USA2$0.16167 per EA filed
Macleods Pharmaceuticals Limited2$0.16167 per EA filed
Novadoz Pharmaceuticals LLC2$0.16167 per EA filed
ScieGen Pharmaceuticals, Inc.2$0.16167 per EA filed
Unichem Pharmaceuticals (USA), Inc.2$0.16167 per EA filed
Apotex Corp.1$0.16167 per EA filed

When these prices took effect

All 21 NDCs, with labeler and price
  • 00591-3796-19 · Actavis Pharma, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 00591-3796-30 · Actavis Pharma, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 29300-0329-13 · Unichem Pharmaceuticals (USA), Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 29300-0329-19 · Unichem Pharmaceuticals (USA), Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 31722-0028-30 · Camber Pharmaceuticals, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 31722-0028-90 · Camber Pharmaceuticals, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 33342-0149-07 · Macleods Pharmaceuticals Limited · $0.16167 per EA · eff. 2026-09-30 filed
  • 33342-0149-10 · Macleods Pharmaceuticals Limited · $0.16167 per EA · eff. 2026-09-30 filed
  • 50228-0428-30 · ScieGen Pharmaceuticals, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 50228-0428-90 · ScieGen Pharmaceuticals, Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 60505-4703-03 · Apotex Corp. · $0.16167 per EA · eff. 2026-09-23 filed
  • 62332-0193-30 · Alembic Pharmaceuticals Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 62332-0193-90 · Alembic Pharmaceuticals Inc. · $0.16167 per EA · eff. 2026-09-23 filed
  • 65862-0879-30 · Aurobindo Pharma Limited · $0.16167 per EA · eff. 2026-09-23 filed
  • 65862-0879-90 · Aurobindo Pharma Limited · $0.16167 per EA · eff. 2026-09-23 filed
  • 67877-0528-30 · Ascend Laboratories, LLC · $0.16167 per EA · eff. 2026-09-23 filed
  • 67877-0528-90 · Ascend Laboratories, LLC · $0.16167 per EA · eff. 2026-09-23 filed
  • 68462-0387-30 · Glenmark Pharmaceuticals Inc., USA · $0.16167 per EA · eff. 2026-09-23 filed
  • 68462-0387-90 · Glenmark Pharmaceuticals Inc., USA · $0.16167 per EA · eff. 2026-09-23 filed
  • 72205-0021-30 · Novadoz Pharmaceuticals LLC · $0.16167 per EA · eff. 2026-09-23 filed
  • 72205-0021-90 · Novadoz Pharmaceuticals LLC · $0.16167 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name solifenacin succinate with SOLIFENACIN 10 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
SOLIFENACIN 5 MG TABLET
generic · tablet, film coated / tablet, coated / tablet
$0.14134 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.82163 per EA filed
Part D 2024 average
SOLIFENACIN 10 MG TABLET this page
generic · tablet, film coated / tablet, coated / tablet, film coated, extended release / tablet
$0.16167 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.82163 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 21 NDCs’ NADAC prices is $0.16167 per EA filed.

Of the 25 other products in FDA’s Cholinergic Muscarinic Antagonist class priced per EA, 17 have a higher middle NADAC price and 8 a lower one. The one in the middle is TOLTERODINE TART ER 2 MG CAP, at $0.2678 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $24.65 for 30 tablets, at an average of $0.82163 per EA in 2024 (2024-01-01 to 2024-12-31) for “Solifenacin Succinate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,379,426 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

19 of the product’s 21 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for SOLIFENACIN 10 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Solifenacin Succinate / Solifenacin Succinate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.